Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference25 articles.
1. Geis GS. Update on clinical development with celecoxib, a new specific COX-2 inhibitor: what can we expect? Scand J Rheumatol. 1999;28:31–7. Suppl.
2. Simon LS, Lanza FL, Lipsky PE. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase-2 inhibitor. Arthritis Rheum. 1998;41:1591–602.
3. Tindall E. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. J Am Osteopath Assoc. 1999;99:S13–7.
4. Paulson SK, Hribar JD, Liu NW, Hajdu EJ, Bible RH, Piergies A, et al. Metabolism and excretion of celecoxib in healthy male volunteers. Drug Metab Dispos. 2000;28:308–14.
5. Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans; effect of food and site of absorption. J Pharmacol Exp Ther. 2001;297(2):638–45.
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献